News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,914 Results
Type
Article (52410)
Company Profile (114)
Press Release (648377)
Multimedia
Podcasts (186)
Webinars (23)
Section
Business (220098)
Career Advice (2890)
Deals (34746)
Drug Delivery (169)
Drug Development (78828)
Employer Resources (179)
FDA (16285)
Job Trends (15108)
News (328976)
Policy (32211)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (2925)
Academic (1)
Accelerated approval (59)
ADA (49)
Adcomms (42)
Allergies (203)
Alliances (47059)
ALS (238)
Alzheimer's disease (1982)
Antibody-drug conjugate (ADC) (575)
Approvals (16699)
Artificial intelligence (821)
ASCO (335)
Autoimmune disease (376)
Automation (64)
Bankruptcy (347)
Best Places to Work (11717)
BIO (72)
BIOSECURE Act (23)
Biosimilars (262)
Biotechnology (92)
Bladder cancer (212)
Brain cancer (80)
Breast cancer (848)
Cancer (6664)
Cardiovascular disease (560)
Career advice (2465)
Career pathing (53)
CAR-T (382)
CDC (75)
Celiac Disease (2)
Cell therapy (1043)
Cervical cancer (59)
Clinical research (69169)
Collaboration (2392)
Commercialization (4)
Company closure (7)
Compensation (1588)
Complete response letters (114)
COVID-19 (2963)
CRISPR (119)
C-suite (1401)
Cystic fibrosis (161)
Data (8937)
Decentralized trials (3)
Denatured (55)
Depression (199)
Dermatology (112)
Diabetes (704)
Diagnostics (7121)
Digital health (64)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (416)
Drug pricing (231)
Drug shortages (39)
Duchenne muscular dystrophy (331)
Earnings (77034)
Editorial (80)
Employer branding (23)
Employer resources (164)
Events (104533)
Executive appointments (1252)
FDA (20445)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1935)
Gene editing (268)
Generative AI (73)
Gene therapy (832)
GLP-1 (1243)
Government (5101)
Grass and pollen (6)
Guidances (426)
Healthcare (19498)
Hematology (194)
HIV (105)
Huntington's disease (72)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (120)
Immunology and inflammation (346)
Immuno-oncology (121)
Indications (228)
Infectious disease (3358)
Inflammatory bowel disease (239)
Inflation Reduction Act (16)
Influenza (151)
Intellectual property (336)
Interviews (532)
IPO (16474)
IRA (57)
Job creations (3671)
Job search strategy (2026)
JPM (70)
Kidney cancer (27)
Labor market (106)
Layoffs (663)
Leadership (56)
Legal (7295)
Licensing (1)
Liver cancer (108)
Longevity (36)
Lung cancer (893)
Lymphoma (484)
Machine learning (67)
Management (64)
Manufacturing (1259)
Marketing (10)
MASH (223)
Medical affairs (1)
Medical device (13642)
Medtech (13833)
Mergers & acquisitions (19673)
Metabolic disorders (1811)
mRNA (269)
Multiple sclerosis (213)
NASH (24)
Neurodegenerative disease (528)
Neuropsychiatric disorders (126)
Neuroscience (3769)
Neurotech (1)
NextGen: Class of 2026 (6792)
Non-profit (4715)
Now hiring (63)
Obesity (856)
Opinion (366)
Ovarian cancer (249)
Pain (290)
Pancreatic cancer (365)
Parkinson's disease (418)
Partnered (36)
Patents (672)
Patient recruitment (825)
Peanut (68)
People (64097)
Pharmaceutical (28)
Pharmacy benefit managers (35)
Phase 1 (21258)
Phase 2 (30448)
Phase 3 (23304)
Pipeline (10461)
Policy (391)
Postmarket research (2395)
Preclinical (8977)
Press Release (72)
Prostate cancer (351)
Psychedelics (78)
Radiopharmaceuticals (364)
Rare diseases (1314)
Real estate (5787)
Recruiting (77)
Regulatory (26111)
Reports (46)
Research institute (2609)
Resumes & cover letters (452)
Rett syndrome (47)
RNA editing (26)
RSV (95)
Schizophrenia (197)
Series A (329)
Series B (245)
Service/supplier (4)
Sickle cell disease (130)
Special edition (31)
Spinal muscular atrophy (185)
Sponsored (52)
Startups (3569)
State (2)
Stomach cancer (20)
Supply chain (144)
Tariffs (99)
The Weekly (128)
Vaccines (1290)
Venture capital (136)
Weight loss (583)
Women's health (139)
Worklife (25)
Date
Today (70)
Last 7 days (435)
Last 30 days (1894)
Last 365 days (30506)
2026 (17777)
2025 (30162)
2024 (34910)
2023 (39605)
2022 (50851)
2021 (55312)
2020 (54154)
2019 (47481)
2018 (35933)
2017 (32981)
2016 (31876)
2015 (37091)
2014 (28567)
2013 (23705)
2012 (24946)
2011 (25873)
2010 (23081)
Location
Africa (916)
Alabama (101)
Alaska (7)
Arizona (305)
Arkansas (15)
Asia (41669)
Australia (7114)
California (13744)
Canada (4002)
China (1629)
Colorado (581)
Connecticut (616)
Delaware (430)
Europe (95944)
Florida (2118)
Georgia (438)
Hawaii (3)
Idaho (64)
Illinois (1134)
India (107)
Indiana (642)
Iowa (24)
Japan (624)
Kansas (135)
Kentucky (52)
Louisiana (56)
Maine (85)
Maryland (1610)
Massachusetts (9903)
Michigan (377)
Minnesota (731)
Mississippi (7)
Missouri (155)
Montana (36)
Nebraska (28)
Nevada (155)
New Hampshire (84)
New Jersey (3734)
New Mexico (30)
New York (3673)
North Carolina (1743)
North Dakota (11)
Northern California (6933)
Ohio (422)
Oklahoma (24)
Oregon (41)
Pennsylvania (2654)
Puerto Rico (33)
Rhode Island (52)
South America (1246)
South Carolina (90)
South Dakota (2)
Southern California (5524)
Tennessee (228)
Texas (2265)
United States (48819)
Utah (408)
Vermont (2)
Virginia (344)
Washington D.C. (83)
Washington State (1124)
West Virginia (4)
Wisconsin (152)
Wyoming (2)
700,914 Results for "aravive biologics formerly known as ruga corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
With PolyPeptide manufacturing peptides such as GLP-1 medicines, Samsung Biologics has identified the deal as a way to tap into fast-growing demand for obesity drug production services.
July 21, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
USP Publishes Product-Specific Emerging Biologics Standards for Public Comment
Advancing efficiency and alignment in biologics development, through product-specific methods, to support broader availability of biologics, including biosimilars, for patients
June 1, 2026
·
4 min read
Insights
From sequence to scale: Gene editing’s new era in biologics manufacturing
In this episode of Denatured, you’ll hear from Jack Crawford, CEO of Demeetra, and Magnus Gustavsson, chief commercial officer at NorthX Biologics. We unpack the evolution of cell line development — CHO cells, targeted integration, transposases and the collaboration models speeding biologics from sequence to GMP.
July 10, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates
July 8, 2026
·
5 min read
Government
Prasad ally Szarama exits CBER after 3 weeks as FDA cleanout continues
After less than three weeks on the job, Katherine Szarama is being replaced by Karim Mikhail as acting head of the Center for Biologics Evaluation and Research. Mikhail had previously spent more than 20 years at Merck and joined the FDA last year.
May 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Allotera Therapeutics (Formerly Wugen) Closes $35 Million Financing to Advance Off-the-Shelf CAR-T Therapies for T-Cell Cancers
July 8, 2026
·
5 min read
IN PARTNERSHIP WITH LOTTE BIOLOGICS
LOTTE Biologics Tightens Global Quality as Syracuse ADC Hub Ramps for 2026
With inspections always on the table, LOTTE Biologics is pushing a proactive, quality first culture across its dual hubs in Syracuse and Songdo, backing its new single‑use ADC facility with rigorous training, self‑audits and real‑time regulatory surveillance.
January 19, 2026
·
2 min read
·
Jennifer C. Smith-Parker
Press Releases
Mighty Therapeutics, Formerly Stealth BioTherapeutics, Announces New Name Honoring the Mitochondrial Disease Community
June 16, 2026
·
6 min read
FDA
FDA taps Szarama as acting CBER director as Prasad’s tumultuous tenure ends
Katherine Szarama, who has served as Prasad’s deputy at the Center for Biologics Evaluation and Research since December, joins a long list of temporary leaders at the Department of Health and Human Services.
May 1, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
June 29, 2026
·
5 min read
1 of 70,092
Next
